Buscar
ESSA Pharma Inc
EPIXAñadir a la lista de seguimiento
0.201USD
0.0000.00%
Cierre 07/02, 13:00（ET）Cotizaciones retrasadas 15 min
8.93MCap. mercado
PérdidaP/E TTM
Más Datos de ESSA Pharma Inc Compañía
ESSA Pharma Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is focused on developing proprietary therapies for the treatment of patients with prostate cancer. Its lead candidate, Masofaniten (formerly EPI-7386), is an oral, small molecule that inhibits the N-terminal domain of the androgen receptor (AR). Masofaniten is in development in combination with antiandrogen treatments in patients with prostate cancer who are earlier in their course of the disease. The Company is completing the clinical development of masofaniten as a monotherapy treatment for patients with metastatic castration-resistant prostate cancer (mCRPC).
Información de ESSA Pharma Inc
Símbolo de cotizaciónEPIX
Nombre de la empresaESSA Pharma Inc
Fecha de salida a bolsaFeb 22, 2021
Director ejecutivoDr. David Ross Parkinson, M.D.
Número de empleados35
Tipo de seguridadOrdinary Share
Fin del año fiscalFeb 22
Dirección999 West Broadway, Suite 720
CiudadVANCOUVER
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísCanada
Código postalV5Z 1K5
Teléfono17783310962
Sitio Webhttps://www.essapharma.com/
Símbolo de cotizaciónEPIX
Fecha de salida a bolsaFeb 22, 2021
Director ejecutivoDr. David Ross Parkinson, M.D.
Ejecutivos de ESSA Pharma Inc
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Jon Adkins
Mr. Jon Adkins
President, Treasurer, Secretary, Director
President, Treasurer, Secretary, Director
--
--
Mr. David Sidney Wood, CPA
Mr. David Sidney Wood, CPA
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Peter Virsik
Mr. Peter Virsik
Chief Operating Officer, Executive Vice President
Chief Operating Officer, Executive Vice President
--
-100.00%
Dr. Alessandra Cesano, M.D., Ph.D.
Dr. Alessandra Cesano, M.D., Ph.D.
Executive Vice President, Chief Medical Officer
Executive Vice President, Chief Medical Officer
--
-100.00%
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Jon Adkins
Mr. Jon Adkins
President, Treasurer, Secretary, Director
President, Treasurer, Secretary, Director
--
--
Mr. David Sidney Wood, CPA
Mr. David Sidney Wood, CPA
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Peter Virsik
Mr. Peter Virsik
Chief Operating Officer, Executive Vice President
Chief Operating Officer, Executive Vice President
--
-100.00%
Dr. Alessandra Cesano, M.D., Ph.D.
Dr. Alessandra Cesano, M.D., Ph.D.
Executive Vice President, Chief Medical Officer
Executive Vice President, Chief Medical Officer
--
-100.00%
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de ESSA Pharma Inc?
Los cinco principales accionistas de ESSA Pharma Inc son: Mr. Jon Adkins
¿Cuántas instituciones poseen acciones de ESSA Pharma Inc (EPIX)?
A fecha de 2025Q3, 79 instituciones poseen acciones de ESSA Pharma Inc, con un valor de mercado combinado de aproximadamente 34.87M, lo que representa el 73.70% del total de acciones. En comparación con el 2025Q2, el accionariado institucional ha aumentado en -13442442.00.